About the Company - Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 22.38 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2022.
| Management |
|---|
| Name | Position Held |
|---|
| Mr. Ramesh Shah | Managing Director |
| Mr. Ketan Shah | Whole Time Director |
| Mr. Romil Shah | Non Executive Director |
| Mrs. Shaila Jain | Independent Director |
| Mr. Satish Beohar | Independent Director |
| Mr. Ashok Kumar Ramawat | Independent Director |
Biofil Chemicals & Pharmaceuticals Ltd. Share Price Update |
|---|
| Share Price | Value |
|---|
| Today | ₹51.65 |
| Previous Day | ₹51.53 |
Basic Stock Data of Biofil Chemicals & Pharmaceuticals Ltd
| Market Cap | 83.4 Cr. |
|---|
| Current Price | 51.3 |
|---|
| High / Low | 65.0/35.1 |
|---|
| Stock P/E | 124 |
|---|
| Book Value | 10.9 |
|---|
| Dividend Yield | 0.00 % |
|---|
| ROCE | 4.73 % |
|---|
| ROE | 3.28 % |
|---|
| Face Value | 10.0 |
|---|
Biofil Chemicals & Pharmaceuticals Ltd Quarterly Results
Biofil Chemicals & Pharmaceuticals Ltd Quarterly Chart
Biofil Chemicals & Pharmaceuticals Ltd Profit & Loss
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|
| Sales | 6.27 | 6.01 | 7.17 | 5.86 | 13.17 | 13.45 | 12.36 | 23.13 | 29.69 | 35.75 | 22.38 | 30.04 | 20.16 |
| Expenses | 5.88 | 5.00 | 6.21 | 5.12 | 12.30 | 10.84 | 11.43 | 22.11 | 27.87 | 34.15 | 21.05 | 28.88 | 18.94 |
| Operating Profit | 0.39 | 1.01 | 0.96 | 0.74 | 0.87 | 2.61 | 0.93 | 1.02 | 1.82 | 1.60 | 1.33 | 1.16 | 1.22 |
| OPM % | 6.22% | 16.81% | 13.39% | 12.63% | 6.61% | 19.41% | 7.52% | 4.41% | 6.13% | 4.48% | 5.94% | 3.86% | 6.05% |
| Other Income | 0.04 | 0.06 | 0.06 | 0.46 | 0.53 | 0.14 | 0.10 | 0.10 | 0.17 | 0.80 | 0.15 | 0.10 | 0.09 |
| Interest | 0.08 | 0.19 | 0.15 | 0.21 | 0.15 | 0.16 | 0.15 | 0.16 | 0.12 | 0.07 | 0.04 | 0.04 | 0.04 |
| Depreciation | 0.19 | 0.21 | 0.22 | 0.25 | 0.26 | 0.28 | 0.30 | 0.37 | 0.41 | 0.41 | 0.43 | 0.43 | 0.44 |
| Profit before tax | 0.16 | 0.67 | 0.65 | 0.74 | 0.99 | 2.31 | 0.58 | 0.59 | 1.46 | 1.92 | 1.01 | 0.79 | 0.83 |
| Tax % | 6.25% | 19.40% | 20.00% | 20.27% | 20.20% | 22.51% | 20.69% | 20.34% | 17.81% | 34.90% | 31.68% | 29.11% | |
| Net Profit | 0.15 | 0.54 | 0.52 | 0.59 | 0.78 | 1.79 | 0.47 | 0.48 | 1.21 | 1.24 | 0.70 | 0.56 | 0.60 |
| EPS in Rs | 0.09 | 0.33 | 0.32 | 0.36 | 0.48 | 1.10 | 0.29 | 0.29 | 0.74 | 0.76 | 0.43 | 0.34 | 0.37 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
Biofil Chemicals & Pharmaceuticals Ltd Profit & Loss Yearly Chart
Biofil Chemicals & Pharmaceuticals Ltd Growth
|
| Compounded Sales Growth |
|---|
| 10 Years:: | 17% |
| 5 Years:: | 19% |
| 3 Years:: | 0% |
| TTM:: | 92% |
Biofil Chemicals & Pharmaceuticals Ltd Growth
|
| Compounded Profit Growth |
|---|
| 10 Years:: | 0% |
| 5 Years:: | 4% |
| 3 Years:: | -23% |
| TTM:: | 18% |
Biofil Chemicals & Pharmaceuticals Ltd Growth
|
| Stock Price CAGR |
|---|
| 10 Years:: | 40% |
| 5 Years:: | 49% |
| 3 Years:: | -43% |
| 1 Year:: | -6% |
Biofil Chemicals & Pharmaceuticals Ltd Growth
|
| Return on Equity |
|---|
| 10 Years:: | 7% |
| 5 Years:: | 5% |
| 3 Years:: | 5% |
| Last Year:: | 3% |
No data available for the Balance Sheet data table.
Biofil Chemicals & Pharmaceuticals Ltd Reserves and Borrowings Chart
Biofil Chemicals & Pharmaceuticals Ltd Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|
| Cash from Operating Activity | -0.21 | -0.12 | 0.21 | 0.01 | 0.14 | 0.71 | 0.46 | 1.26 | 0.89 | 1.11 | -0.22 | -0.11 |
| Cash from Investing Activity | -0.82 | -0.30 | -0.24 | -0.17 | -0.19 | -0.48 | -0.38 | -1.41 | -0.21 | -0.10 | -0.07 | -0.01 |
| Cash from Financing Activity | 1.19 | 0.30 | 0.07 | 0.11 | 0.10 | -0.11 | -0.02 | -0.08 | -0.57 | -0.83 | -0.01 | 0.02 |
| Net Cash Flow | 0.16 | -0.12 | 0.04 | -0.05 | 0.05 | 0.13 | 0.06 | -0.24 | 0.12 | 0.18 | -0.30 | -0.11 |
|
Biofil Chemicals & Pharmaceuticals Ltd Financial Efficiency Indicators Chart
No valid data available for the Shareholding
Biofil Chemicals & Pharmaceuticals Ltd Shareholding Pattern Chart
No. of Biofil Chemicals & Pharmaceuticals Ltd Shareholders
This stock is not held by any mutual fund
Biofil Chemicals & Pharmaceuticals Ltd ROCE Trend
Biofil Chemicals & Pharmaceuticals Ltd EPS Trend
Biofil Chemicals & Pharmaceuticals Ltd Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.29 | 0.44 | 0.76 | 0.74 | 0.30 |
| Diluted EPS (Rs.) | 0.29 | 0.44 | 0.76 | 0.74 | 0.30 |
| Cash EPS (Rs.) | 0.60 | 0.69 | 1.01 | 0.99 | 0.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 10.63 | 10.35 | 9.91 | 9.14 | 8.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 10.63 | 10.35 | 9.91 | 9.14 | 8.39 |
| Revenue From Operations / Share (Rs.) | 18.46 | 13.75 | 21.97 | 18.24 | 14.21 |
| PBDIT / Share (Rs.) | 0.77 | 0.91 | 1.47 | 1.23 | 0.69 |
| PBIT / Share (Rs.) | 0.51 | 0.64 | 1.22 | 0.97 | 0.46 |
| PBT / Share (Rs.) | 0.48 | 0.62 | 1.18 | 0.89 | 0.36 |
| Net Profit / Share (Rs.) | 0.34 | 0.42 | 0.76 | 0.74 | 0.29 |
| PBDIT Margin (%) | 4.21 | 6.62 | 6.71 | 6.71 | 4.85 |
| PBIT Margin (%) | 2.78 | 4.71 | 5.55 | 5.34 | 3.27 |
| PBT Margin (%) | 2.64 | 4.53 | 5.36 | 4.93 | 2.58 |
| Net Profit Margin (%) | 1.86 | 3.12 | 3.47 | 4.06 | 2.08 |
| Return on Networth / Equity (%) | 3.23 | 4.14 | 7.69 | 8.11 | 3.53 |
| Return on Capital Employeed (%) | 4.72 | 6.12 | 12.05 | 10.65 | 5.55 |
| Return On Assets (%) | 1.78 | 3.72 | 3.73 | 2.84 | 1.99 |
| Total Debt / Equity (X) | 0.03 | 0.02 | 0.02 | 0.08 | 0.11 |
| Asset Turnover Ratio (%) | 1.20 | 0.86 | 0.94 | 0.89 | 0.95 |
| Current Ratio (X) | 1.63 | 6.23 | 1.40 | 1.17 | 1.32 |
| Quick Ratio (X) | 1.54 | 5.37 | 1.14 | 1.11 | 1.20 |
| Inventory Turnover Ratio (X) | 3.13 | 0.80 | 2.27 | 2.81 | 0.69 |
| Interest Coverage Ratio (%) | 29.76 | 36.53 | 35.23 | 16.42 | 7.01 |
| Interest Coverage Ratio (Post Tax) (%) | 14.19 | 18.20 | 19.23 | 10.94 | 4.01 |
| Enterprise Value (Cr.) | 67.92 | 94.38 | 106.83 | 12.98 | 12.26 |
| EV / Net Operating Revenue (X) | 2.26 | 4.22 | 2.99 | 0.43 | 0.52 |
| EV / EBITDA (X) | 53.71 | 63.64 | 44.53 | 6.51 | 10.91 |
| MarketCap / Net Operating Revenue (X) | 2.25 | 4.20 | 2.99 | 0.40 | 0.46 |
| Price / BV (X) | 3.90 | 5.59 | 6.62 | 0.80 | 0.78 |
| Price / Net Operating Revenue (X) | 2.25 | 4.20 | 2.99 | 0.40 | 0.46 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.10 | 0.04 |
Biofil Chemicals & Pharmaceuticals Ltd Profitability Ratios (%)
Biofil Chemicals & Pharmaceuticals Ltd Liquidity Ratios
Biofil Chemicals & Pharmaceuticals Ltd Liquidity Ratios (%)
Biofil Chemicals & Pharmaceuticals Ltd Interest Coverage Ratios (%)
Biofil Chemicals & Pharmaceuticals Ltd Valuation Ratios
Fair Value of Biofil Chemicals & Pharmaceuticals Ltd Stock
Fair Value: ₹45.22
The stock is overvalued by 11.85% compared to the current price ₹51.3
*Investments are subject to market risks
Strength and Weakness of Biofil Chemicals & Pharmaceuticals Ltd Stock
Unable to fetch valid data for stock valuation.
